Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, August 17, 2014 12:27:06 PM
bullish
## source: finance.yahoo.com
Thu, 14 Aug 2014 18:42:20 GMT ~ SEC probing Valeant, Ackman's hostile Allergan bid - WSJ
[Reuters] - A hostile takeover bid by billionaire investor William Ackman and Valeant Pharmaceuticals International Inc to acquire Allergan Inc is being investigated by federal regulators for possible violations of securities laws, the Wall Street Journal reported, citing people familiar with the matter. The Securities and Exchange Commission civil probe was focused on potential breaches of insider trading laws, the Journal reported, citing one of the people. Earlier this month, Botox maker Allergan accused Valeant and Ackman of violating securities laws by using insider information as they prepared a takeover bid for the drug company.
read full: http://finance.yahoo.com/news/sec-probing-valeant-ackmans-hostile-184220263.html
*********************************************************
Wed, 13 Aug 2014 19:54:44 GMT ~ Vertex leads S&P 500, King drops on outlook
read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=D058BDD8-2256-11E4-9C1E-00212803FAD6&siteid=yhoof2
*********************************************************
Wed, 13 Aug 2014 18:42:21 GMT ~ Vertex to end sales of hepatitis C drug Incivek
read full: http://finance.yahoo.com/news/vertex-end-sales-hepatitis-c-184221942.html
*********************************************************
Wed, 13 Aug 2014 13:58:54 GMT ~ Shares Rise, as Biotech Gains Offset Listless Retail Sales
read full: http://www.nytimes.com/2014/08/14/business/daily-stock-market-activity.html?partner=yahoofinance
*********************************************************
Tue, 12 Aug 2014 15:00:38 GMT ~ From Riches to Rags: Vertex Discontinues Incivek as Sales Evaporate
read full: http://blogs.wsj.com/pharmalot/2014/08/12/from-riches-to-rags-vertex-discontinues-incivek-as-sales-evaporate/?mod=yahoo_hs
*********************************************************
$VRTX charts
basic chart ## source: stockcharts.com
basic chart ## source: eoddata.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$VRTX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/VRTX/company-info
Ticker: $VRTX
OTC Market Place: Not Available
CIK code: 0000875320
Company name: Vertex Pharmaceuticals Inc.
Company website: http://www.vpharm.com
Incorporated In: MA, USA
$VRTX share structure
## source: otcmarkets.com
Market Value: $21,636,849,719 a/o Aug 15, 2014
Shares Outstanding: 238,081,533 a/o Jul 25, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$VRTX extra dd links
Company name: Vertex Pharmaceuticals Inc.
Company website: http://www.vpharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=VRTX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=VRTX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=VRTX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/news - http://finance.yahoo.com/q/h?s=VRTX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/VRTX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=VRTX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/VRTX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Vertex+Pharmaceuticals+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Vertex+Pharmaceuticals+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Vertex+Pharmaceuticals+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.vpharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.vpharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.vpharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/VRTX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000875320&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=VRTX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=VRTX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=VRTX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=VRTX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=VRTX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=VRTX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=VRTX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/VRTX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=VRTX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/VRTX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=VRTX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/VRTX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/VRTX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/VRTX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=VRTX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=VRTX
$VRTX DD Notes ~ http://www.ddnotesmaker.com/VRTX
Recent VRTX News
- VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES • PR Newswire (US) • 04/23/2024 04:45:00 AM
- VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES • PR Newswire (US) • 04/23/2024 04:45:00 AM
- VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES • PR Newswire (Canada) • 04/23/2024 04:45:00 AM
- Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain • Business Wire • 04/18/2024 12:00:00 PM
- Costco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More News • IH Market News • 04/11/2024 11:24:54 AM
- Vertex Enters Into Agreement to Acquire Alpine Immune Sciences • Business Wire • 04/10/2024 08:01:00 PM
- Vertex Enters Into Agreement to Acquire Alpine Immune Sciences • Business Wire • 04/10/2024 08:01:00 PM
- Vertex to Announce First Quarter 2024 Financial Results on May 6 • Business Wire • 04/09/2024 08:05:00 PM
- Vertex Announces New Drug Submission for Exagamglogene Autotemcel (exa-cel) Has Been Accepted for Priority Review by Health Canada for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia • PR Newswire (Canada) • 04/01/2024 03:00:00 PM
- Vertex annonce que la présentation de drogue nouvelle d'Exagamglogène Autotemcel (exa-cel) a été acceptée pour évaluation prioritaire par Santé Canada pour le traitement de l'anémie falciforme et de la bêta-thalassémie dépendante des transfusion • PR Newswire (Canada) • 04/01/2024 03:00:00 PM
- Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease • Business Wire • 04/01/2024 12:00:00 PM
- Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) • Business Wire • 03/21/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:08:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:02:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:59:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:55:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:50:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:44:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:37:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:29:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:24:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 06:19:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 04:25:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 04:10:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 03:52:48 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM